Tocilizumab Utilization for Coronavirus Disease 2019: A Case Series
Conclusions
Tocilizumab may play a role in treating patients with COVID-19 with elevated IL-6 levels, who are classified as severely ill and treated early in their disease course. The risks of adverse events and economic burdens should also be evaluated.
Source: Infectious Diseases in Clinical Practice - Category: Infectious Diseases Tags: Original Articles Source Type: research
More News: Academia | Actemra | Coronavirus | COVID-19 | Infectious Diseases | Laboratory Medicine | Respiratory Medicine